// App-Quantinova.ai

1256-180 : PROGNOSTIC VALUE OF NEUTROPHIL/LYMPHOCYTE RATIO IN PATIENTS WITH STEMI UNDERGOING PRIMARY CORONARY INTERVENTION: TEN-YEAR FOLLOW-UP RESULTS OF MULTICENTER EXPERIENCES

Researchers

Presenter

  • Mehmet Kaya

Principal Investigators

  • Mahmut Akpek

  • Turgay Celik

  • C. Micheal Gibson

Medical Centers

  • Erciyes University School of Medicine, Kayseri, Turkey

Locations

  • Turkey

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Acute Coronary Syndromes

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim